Ocular Surface Changes After Switching from Other Prostaglandins to Tafluprost and Preservative-Free Tafluprost in Glaucoma Patients

PURPOSE: To study ocular surface disease (OSD) changes after switching from preserved prostaglandin analogues monotherapy to preserved tafluprost and preservative-free (PF) tafluprost in primary open-angle glaucoma patients. METHODS: Glaucoma patients treated with preserved prostaglandins (except ta...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Ophthalmol
Auteurs principaux: Ruangvaravate, Ngamkae, Choojun, Karnthida, Srikulsasitorn, Benjawan, Chokboonpiem, Jatupol, Asanatong, Dechathon, Trakanwitthayarak, Supaporn
Format: Artigo
Langue:Inglês
Publié: Dove 2020
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7548342/
https://ncbi.nlm.nih.gov/pubmed/33116362
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S264984
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires